InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Flowers Cynthia Louise, Directeur. Insider active across 5 companies, notably Kadmon Holdings, Inc.. In total, 10 filings have been recorded. History available since 8 November 2021. The latest transaction was disclosed on 9 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Cynthia Louise Flowers is Director at LISATA THERAPEUTICS, INC., G1 Therapeutics, Inc., Caladrius Biosciences, INC., and Kadmon Holdings, Inc. She has 10 filings in total, and across the 10 sampled filings, the most common transaction nature is attribution, with a date range from 2021-11-09 to 2026-01-13. The buy and sell amounts are both 0 in this recent sample.